FUNDAMENTALS
EdgeFII/DII
APOLLOHOSPApollo Hospitals
₹9,200.00+5.29%
Terminal
  • Overview
  • Price
  • Ratios
  • About
  • P&L
  • Balance
  • Cash flow
  • Holders
  • Actions
  • Peers
  • News
APOLLOHOSPNSE · EquityHealthcare Services

Apollo Hospitals

ISIN
INE437A01024
Instrument key
NSE_EQ|INE437A01024
Open in terminal Fundamentals cached for 6 hours
Last traded price
₹9,200.00+462.00 · +5.29%
Day rangecircuit ₹8,280.00 – ₹10,120.00
8,800.00
9,282.50

as of 21/11/2026, 6:31:39 pm

Open
₹8,820.00
Day high
₹9,282.50
Day low
₹8,800.00
Prev. close
₹8,738.00
Volume
14.13 L
VWAP
₹9,142.36

On this page

Company

  • Overview
  • Price chart
  • Key ratios
  • About

Statements

  • Profit & loss
  • Balance sheet
  • Cash flow

Ownership

  • Shareholding
  • Corporate actions
  • Peers

Market

  • News

02/Price history

Price chart

1 year · daily candles. Hover the chart for the OHLC of any candle; the table below holds the same data row by row.

1D1W1M6M1Y5YMAX
Change · 1Y
+24.48%
7,391.00 → 9,200.00
Period high
₹9,282.50
20/11/2026
Period low
₹6,696.50
23/1/2026
From high
-0.89%
+37.39% from low
Avg volume
4.27 L
10.59 Cr total
Volatility · ann.
22.1%
248 candles · 128 up / 119 down
20 Nov 2026O 8,820.00H 9,282.50L 8,800.00C 9,200.00Vol 14.13 L
SMA 20SMA 50Averages need 50 candles before they begin
Candle data248 rows of open, high, low, close and volumeShowHide
20 Nov 20268,820.009,282.508,800.009,200.00+4.31%482.5014.13 L
19 Nov 20268,777.008,810.008,690.008,738.00-0.44%120.003.17 L
18 Nov 20268,799.008,898.508,675.008,821.00+0.25%223.505.11 L
17 Nov 20268,770.008,819.008,712.508,712.50-0.66%106.504.89 L
16 Nov 20268,565.008,786.508,534.508,771.00+2.41%252.006.06 L
13 Nov 20268,515.008,640.008,490.008,526.00+0.13%150.005.56 L
12 Nov 20268,537.508,537.508,454.508,515.00-0.26%83.003.48 L
11 Nov 20268,595.008,604.008,477.008,604.00+0.10%127.004.27 L
9 Nov 20268,499.008,575.008,457.008,549.50+0.59%118.004.99 L
8 Nov 20268,515.008,515.008,428.508,430.00-1.00%86.5028.3K

Historical price and volume data · Showing 1–10 of 248

1 / 25

03/Valuation & returns

Key ratios vs sector

Company value benchmarked against the sector median. The ratio set is sector specific — banks report NIM, CASA and Net NPA instead of EV/EBITDA.

P/E

Price ÷ earnings per share

56.53
Company
56.53
Sector
55.28

Worse than sector by 2%

P/B

Price ÷ book value per share

12.46
Company
12.46
Sector
3.05

Worse than sector by 309%

ROA

Net income ÷ total assets

9.65%
Company
9.65%
Sector
4.2%

Better than sector by 130%

ROE

Net income ÷ shareholders' equity

21.14%
Company
21.14%
Sector
-31.98%

Better than sector by 166%

ROCE

EBIT ÷ capital employed

18.94%
Company
18.94%
Sector
11.89%

Better than sector by 59%

Quick Ratio

Liquid assets ÷ current liabilities

0.98
Company
0.98
Sector
32.98

Worse than sector by 97%

EV/EBITDA

Enterprise value ÷ EBITDA

29.71
Company
29.71
Sector
23.22

Worse than sector by 28%

04/Business

About the company

Sector: Healthcare Services

Apollo Hospitals Enterprise Limited is an integrated healthcare company. It is engaged in the business of providing hospital services and selling pharma and wellness products through a network of pharmacies, including the operation of multidisciplinary private hospitals, clinics, diagnostic centers and pharmacies. It is engaged in hospitals and hospitals-based services. The Company's segments include Healthcare Services, Retail Health and Diagnostics, Digital Health and Pharmacy Distribution, and Others. Retail Health and Diagnostics segment includes clinics and diagnostics. Digital Health and Pharmacy Distribution segment is engaged in the business of procurement and distribution of pharmaceuticals, fast-moving consumer goods and private label products business from various services using the digital platform. The Company has approximately 10,000 plus beds across 73 hospitals, 5000 plus pharmacies and 378 plus clinics and diagnostic centers, as well as 200 telemedicine centers.

Sector market cap (INR)
₹1,32,139 Cr

reported in crore

Sector market cap (USD)
$14.68B

reported in billion

Market capitalisation is reported at the sector-constituent level, not the standalone company level.

05/Profit & loss

Consolidated income statement

Quarterly figures in ₹ crore. Growth marked reported is provided; margins are derived.

YearlyQuarterly
ConsolidatedStandalone
Revenue · Sep 2026
₹7,660 Cr
+9.74% vs Jun 2026
Net profit · Sep 2026
₹660 Cr
+8.04% vs Jun 2026
Operating margin
11.8%
was 11.6%
Revenue CAGR · 4p
5.5%
profit 8.5% · op 9.8%
Filed order
Revenue7,6606,9806,6496,530
Revenue growthreported9.7%5.0%1.8%—
Operating profit903808722682
Operating profit growthreported11.8%12.0%5.8%—
Operating marginderived11.8%11.6%10.9%10.4%
Net profit660610551516
Net profit growthreported8.0%10.7%6.8%—
Net marginderived8.6%8.7%8.3%7.9%
EPS — basic₹/share, annual——135.04—

Figures in ₹ crore. Margin rows are computed from the reported values.

Full annual line itemsRevenue, other income, expenses, tax, EPSShowHide
Filed order
Revenue25,22921,79419,05916,613
Other Income19220010690
Total Revenue25,42021,99419,16616,703
Total Expenses22,78519,98817,80515,559
Profit Before Tax2,6612,0391,3811,144
Tax658534446256
Profit After Tax2,0031,505935888
EPS - Basic135.04100.5662.5056.97
EPS - Diluted134.94100.5662.5056.97

This breakdown is available annually, even when the summary above is quarterly. EPS rows are per share.

06/Balance sheet

Consolidated balance sheet

Only annual balance sheets are available — the quarterly filter does not apply here. Figures in ₹ crore; net worth is assets minus liabilities.

ConsolidatedStandalone
Total assets · Mar 2026
₹22,197 Cr
+7.45% YoY
Total liabilities
₹12,222 Cr
Net worth
₹9,975 Cr
Liabilities ÷ assets
55.1%
lower means a lighter balance sheet
Filed order
Total assets22,19720,65716,75314,428
Total liabilities12,22212,0059,4337,897
Net worthderived9,9758,6537,3206,531
Liabilities ÷ assetsderived55.1%58.1%56.3%54.7%
Asset growthderived7.5%23.3%16.1%—

Figures in ₹ crore. Stacked chart height equals total assets.

Full annual line itemsNon-current & current assets, liabilities, equity capitalShowHide
Filed order
Non-Current Assets15,29713,62911,47310,091
Current Assets6,9007,0295,2804,337
Total Assets22,19720,65716,75314,428
Current Liabilities6,4814,5794,6653,325
Net Current Asset4192,4506151,012
Non-Current Liabilities5,7417,4264,7684,572
Equity Capital9,9758,6537,3216,531
Total Equity & Liabilities22,19720,65716,75314,428

Figures in ₹ crore unless the line item is per-share.

07/Cash flow

Consolidated cash flow

Annual only, in ₹ crore. Negative values are outflows, so healthy companies usually show positive operating and negative investing cash flow.

ConsolidatedStandalone
Operating · Mar 2026
₹2,856 Cr
+33.67% YoY
Investing
-₹2,148 Cr
Financing
-₹478 Cr
Free cash flow
₹708 Cr
operating + investing
Filed order
Operating activities2,8562,1361,9201,377
Operating changereported33.7%11.3%39.5%—
Investing activities-2,148-3,383-1,537-871
Investing changereported36.5%-120.1%-76.6%—
Financing activities-4781,319-311-633
Financing changereported-136.2%524.2%50.9%—
Net cash flowderived2307372-127
Free cash flowoperating + investing708-1,247383506

Figures in ₹ crore.

Full annual line itemsProfit before tax through closing cash balanceShowHide
Filed order
Profit before tax2,0031,505935844
Income before WC changes4,0363,2262,5802,209
Change in Assets-770-594-641-782
Change in Liabilities196-9448332
Change in WC-574-604-193-450
Cash flow from Operations2,8562,1361,9201,377
Cash flow from Investing-2,148-3,383-1,537-871
Cash flow from Financing-4781,319-311-633
Total Cash Flow2307372-127
Cash (Start of the year)578506433547
Cash (End of the year)811578506433

Figures in ₹ crore unless the line item is per-share.

08/Ownership

Shareholding pattern

Percentage of total shares by holder category across the last 4 reported quarters. Sort any quarter column to rank holders by size.

Promoters
28.02%
0.00 pts QoQ
FII
43.18%
+1.68 pts QoQ
DII (other)
4.88%
-1.51 pts QoQ
Mutual funds
17.19%
-0.14 pts QoQ
Retail & others
6.72%
-0.05 pts QoQ
Filed order
Promoters28.0%28.0%28.0%28.0%
FII43.2%41.5%42.6%43.5%
DII (other)4.9%6.4%6.1%4.8%
Mutual funds17.2%17.3%16.6%16.8%
Retail & others6.7%6.8%6.6%6.9%
Promoters — QoQ changepts, derived0.0%0.0%0.0%—
FII — QoQ changepts, derived1.7%-1.1%-0.9%—
DII (other) — QoQ changepts, derived-1.5%0.3%1.4%—
Mutual funds — QoQ changepts, derived-0.1%0.7%-0.1%—
Retail & others — QoQ changepts, derived-0.0%0.2%-0.3%—
Totalderived100.0%100.0%100.0%100.0%

Values are percentages of total outstanding shares; QoQ rows are percentage-point moves.

09/Events

Corporate actions

Dividends, bonuses, splits and rights issues. Filter by type, sort by any date, and expand a row for the full event detail.

DividendFinal₹10.00200.0%14 Aug 202614 Aug 202620 May 2026
DividendInterim₹10.00200.0%16 Feb 202616 Feb 202610 Feb 2026

10/Comparison

Peers & competitors

Competitor set priced live. Filter by sector, sort any column, and expand a peer for its business description.

Sector
MAXHEALTHMAX Healthcare INS LtdHealthcare Services₹1,081.00+3.88%95.32 L₹1,05,080 Cr$11.68B
MANIPALHOSManipal Health Enterpri LHealthcare₹702.20+0.83%11.62 L₹92,366 Cr$10.26B
ASTERDMAster DM Quality Care LtdHealthcare Services₹779.30+5.41%26.66 L₹67,960 Cr$7.55B
FORTISFortis Healthcare LtdHealthcare Services₹825.00+1.87%22.88 L₹62,284 Cr$6.92B
MEDANTAGlobal Health LimitedHealthcare Services₹1,480.20+0.13%2.65 L₹39,829 Cr$4.43B
NHNarayana Hrudayalaya Ltd.Healthcare Services₹1,945.00+3.84%7.85 L₹39,757 Cr$4.42B
LALPATHLABDR. LAL Path Labs Ltd.Healthcare Services₹1,989.00+1.31%2.65 L₹33,680 Cr$3.74B
KIMSKrishna Inst Of MED SCI LHealthcare Services₹795.60+3.62%10.44 L₹33,483 Cr$3.72B
SYNGENESyngene International LtdDiversified₹451.70+3.28%25.58 L₹18,240 Cr$2.03B
MOLBIOMolbio Diagnostics LtdHealthcare₹1,495.50-2.02%7.01 L₹17,228 Cr$1.91B

Market cap is the sector-constituent figure reported per peer · Showing 1–10 of 10

1 / 1

11/Coverage

Company news

Articles published in the last seven days, paginated by the provider.

5102050
  • Thumbnail: Top gainers and losers, Nov 20: Apollo Hospitals, Axis Bank soar 5%, Titan, Tata Steel 2%; check list
    yesterday20/11/2026, 4:45:04 pm
    Top gainers and losers, Nov 20: Apollo Hospitals, Axis Bank soar 5%, Titan, Tata Steel 2%; check list

    On November 20, the SENSEX closed higher by 897.96 points or 1.08% at 83,919.71, while the NIFTY50 gained 286.30 points, or 1.12%, to end at 25,800.60.

  • Thumbnail: Market wrap, Nov 20: NIFTY50 ends at 25,801, SENSEX jumps 898 pts; NIFTY Bank at record high, Apollo Hospitals leads
    yesterday20/11/2026, 4:06:10 pm
    Market wrap, Nov 20: NIFTY50 ends at 25,801, SENSEX jumps 898 pts; NIFTY Bank at record high, Apollo Hospitals leads

    The broader market, however, closed mixed with the Nifty Midcap 100 rising 0.66% to settle at the 62,031 level, while the Nifty Smallcap 100 dropped 0.13% to end at the 19,443.60 level.

  • Thumbnail: ICICI Bank to Meesho: Top 5 stocks hit record highs on November 20; how much have they gained?
    yesterday20/11/2026, 3:16:27 pm
    ICICI Bank to Meesho: Top 5 stocks hit record highs on November 20; how much have they gained?

    Several stocks, including big names like ICICI Bank, Axis Bank, among others have rallied to hit a fresh record high on Friday, November 20, with investors focusing on the sustained FII buying support and the trend reversal powering the intraday gains.

  • Thumbnail: NIFTY50, SENSEX gain 1%, NIFTY Bank scales new record high: Key triggers explained
    yesterday20/11/2026, 2:18:41 pm
    NIFTY50, SENSEX gain 1%, NIFTY Bank scales new record high: Key triggers explained

    NIFTY Bank hits a record high for the third time in a week on Friday and crosses the 64,500 level for the first time.

  • Thumbnail: Max Healthcare, Apollo Hospitals, other healthcare stocks surge over 5% despite volatile market; what’s behind the surge?
    yesterday20/11/2026, 11:17:17 am
    Max Healthcare, Apollo Hospitals, other healthcare stocks surge over 5% despite volatile market; what’s behind the surge?

    Healthcare stocks like Apollo Hospitals and Max Healthcare, among others, were witnessing buying momentum in an overall volatile market on Friday, November 20, as investors focused on the constructive outlook despite the selling pressure from the global markets.

Showing 1–5 of 6 articles

1 / 2